IDERA PHARMACEUTICALS, INC. STOCK PURCHASE AGREEMENT December 8, 2006Stock Purchase Agreement • August 5th, 2010 • Idera Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • New York
This Stock Purchase Agreement (this “Agreement”) is entered into as of the date set forth above by and between Idera Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Merck & Co., Inc., a New Jersey corporation (“Merck”). The parties hereby agree as follows:
CONSULTING AGREEMENTConsulting Agreement • August 5th, 2010 • Idera Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • Massachusetts
THIS CONSULTING AGREEMENT (the “Agreement”), made this 1st day of August, 2010 (“Effective Date”), is entered into by Idera Pharmaceuticals, Inc., a Delaware corporation with its principal place of business at 167 Sidney Street, Cambridge, MA 02139 (the “Company”), and Bexon Clinical Consulting, LLC a limited liability company located at 142 Grove Street, Montclair, New Jersey 07042 (the “Consultant”). Company and Consultant may be referred to herein individually as a “Party” and collectively as the “Parties.”
